118th Congress Health
H.R. 3503: NIH Clinical Trial Diversity Act of 2023
Introduced
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill sets out requirements to increase the diversity of clinical trial participants and requires other activities to foster participation in clinical trials.
As a condition of approval from the National Institutes of Health (NIH) for a clinical trial investigating a drug, device, or behavioral intervention, a sponsor's application must include certain information related to diversity in its trial, such as
- goals for recruiting and retaining trial participants,
- plans for achieving the recruitment and retention goals and implementing less-burdensome clinical trial follow-up requirements, and
- requirements for researchers and other individuals involved with the trial to complete education and training about diversity in clinical trials.
Read the full summary
A sponsor must also annually share demographic data of clinical trial participants with the NIH. The NIH must publish on its website information about the diversity of and other information concerning the clinical trials it funds.
If a sponsor fails to meet its diversity goals or related requirements, the sponsor must develop and implement a strategic plan to increase the diversity of the clinical trial participants.
Further, the NIH and the Food and Drug Administration must carry out a national campaign to increase awareness about the need for diverse clinical trials.
The bill also requires studies on barriers to participation in clinical trials. The Government Accountability Office must study actions taken by federal agencies to address such barriers while the NIH must study regulations that govern reimbursements of out-of-pocket expenses of and incentives for clinical trial participants.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Brian Fitzpatrick R-PAOriginal
- Anna Eshoo D-CA
- Gwen Moore D-WI
- Eleanor Norton D-DC
- Debbie Wasserman Schultz D-FL
- Nanette Barragán D-CA
- Alma Adams D-NC
- Yvette Clarke D-NY
- Dean Phillips D-MN
- Tony Cárdenas D-CA
- Pramila Jayapal D-WA
- Colin Allred D-TX
- William Keating D-MA
- Sean Casten D-IL
- Ted Lieu D-CA
- Mark Pocan D-WI
- Lisa Blunt Rochester D-DE
- James Himes D-CT
- Henry Johnson D-GA
- Brittany Pettersen D-CO
- Seth Magaziner D-RI
- Bonnie Watson Coleman D-NJ
- Jill Tokuda D-HI
- Yadira Caraveo D-CO
- Andy Kim D-NJ
- Josh Gottheimer D-NJ
- Sheila Jackson Lee D-TX
- Joe Neguse D-CO
- Joseph Morelle D-NY
- Becca Balint D-VT
- Mark DeSaulnier D-CA
- Stephen Lynch D-MA
- Grace Napolitano D-CA
- Scott Peters D-CA
- Jason Crow D-CO
- Jennifer McClellan D-VA
- Paul Tonko D-NY
- Mary Peltola D-AK
- Jerrold Nadler D-NY
- Melanie Stansbury D-NM
Who scored on this bill
- 1Robin Kelly SponsorDrew cross-party cosponsors, introduced, reached a cosponsor milestone3 events+12
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Robin Kelly
History
- Introduced in the House by Robin Kelly.
Show the full action history (3 actions)
- Referred to the Subcommittee on Health.
- Introduced in House
- Referred to the House Committee on Energy and Commerce.


